Halozyme Therapeutics, Inc. (HALO)

NASDAQ: HALO · Real-Time Price · USD

52.21

-0.32 (-0.61%)

At close: Jun 27, 2025, 4:00 PM

52.60

+0.39 (0.75%)

After-hours: Jun 27, 2025, 6:55 PM EDT

Halozyme Therapeutics Market Cap

Halozyme Therapeutics has a market cap or net worth of $6.43 billion as of June 27, 2025. Its market cap has decreased by -1.20% in one year.

Market Cap

6.43B

Enterprise Value

7.22B

1-Year Change

-1.20%

Ranking

#1139

Market Cap Chart

Since March 16, 2004, Halozyme Therapeutics's market cap has increased from $8.10M to $6.43B, an increase of 79,324.30%. That is a compound annual growth rate of 36.83%.

Market Cap History

Date	Market Cap	% Change
Jun 26, 2025	6.47B	6.41%
Dec 31, 2024	6.08B	24.59%
Dec 29, 2023	4.88B	-36.54%
Dec 30, 2022	7.69B	35.91%
Dec 31, 2021	5.66B	-1.95%
Dec 31, 2020	5.77B	122.23%
Dec 31, 2019	2.60B	22.85%
Dec 31, 2018	2.11B	-26.67%
Dec 29, 2017	2.88B	125.43%
Dec 30, 2016	1.28B	-42.33%
Dec 31, 2015	2.22B	83.35%
Dec 31, 2014	1.21B	-29.21%
Dec 31, 2013	1.71B	126.01%
Dec 31, 2012	756.30M	-23.30%
Dec 30, 2011	986.10M	23.98%
Dec 31, 2010	795.40M	47.84%
Dec 31, 2009	538.00M	17.96%
Dec 31, 2008	456.10M	-17.36%
Dec 31, 2007	551.90M	6.38%
Dec 29, 2006	518.80M	469.48%
Dec 30, 2005	91.10M	-13.07%
Dec 31, 2004	104.80M	1,193.83%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	718.04B
Johnson & Johnson	366.90B
AbbVie	329.86B
Novo Nordisk	299.93B
UnitedHealth Group	277.32B
Novartis AG	235.02B
Abbott Laboratories	233.69B
AstraZeneca	215.99B

Market Cap Rankings